Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma

Published:2013-07-05 Issue:1 Volume:115 Page:71-77
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Zhang Jun-Ping,Lee Eudocia Q.,Nayak Lakshmi,Doherty Lisa,Kesari Santosh,Muzikansky Alona,Norden Andrew D.,Chen Huichao,Wen Patrick Y.,Drappatz Jan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-013-1196-1.pdf

Reference20 articles.

1. Bernstein SH, Unger JM, Leblanc M, Friedberg J, Miller TP, Fisher RI (2009) Natural history of CNS relapse in patients with aggressive non-Hodgkin’s lymphoma: a 20-year follow-up analysis of SWOG 8516: the Southwest Oncology Group. J Clin Oncol 27:114–119

2. Gerstner ER, Batchelor TT (2010) Primary central nervous system lymphoma. Arch Neurol 67:291–297

3. Arellano-Rodrigo E, Lopez-Guillermo A, Bessell EM, Nomdedeu B, Montserrat E, Graus F (2003) Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma. Eur J Haematol 70:219–224

4. Plotkin SR, Betensky RA, Hochberg FH, Grossman SA, Lesser GJ, Nabors LB, Chon B, Batchelor TT (2004) Treatment of relapsed central nervous system lymphoma with high-dose methotrexate. Clin Cancer Res 10:5643–5646

5. Makino K, Nakamura H, Hide T, Kuratsu J (2012) Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status. J Neurooncol 106:155–160

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot Study of High-Dose Pemetrexed in Patients with Progressive Chordoma;Clinical Cancer Research;2023-12-04

2. Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma;Hematology;2023-08-07

3. Specific KIR-HLA genotypes predict the outcomes of refractory or recurrent primary central nervous system lymphoma;2022-10-11

4. Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study;Frontiers in Oncology;2022-07-11

5. Pemetrexed for Recurrent Primary Central Nervous System Lymphoma in the Elderly: Results of a Retrospective Study;Journal of Healthcare Engineering;2022-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3